C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2011
11/23/2011	EP1389133B1 Methods for inactivating viruses
11/23/2011	EP1297109B1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
11/23/2011	CN102257135A Production of viral vaccine
11/23/2011	CN102257134A Methods using ion exchange and gel filtration chromatography for poxvirus purification
11/23/2011	CN102256611A Anti-viral protection with viruses containing defective genome segments
11/23/2011	CN102250917A Method for preparing IL28B and special recombinant bacterium
11/23/2011	CN102250908A Rice seed 26kD globulin Glb-1 gene terminator and application thereof
11/23/2011	CN102250907A Rice glutelin gene GluA-2 terminator and use thereof
11/23/2011	CN102250906A Rice seed glutelin GluD-1 gene terminator and application thereof
11/23/2011	CN102250905A Rice seed 16kD gliadin gene terminator and application thereof
11/23/2011	CN102250904A Medicine for preventing and/or treating melanoma
11/23/2011	CN102250864A Dual purposes of linoleate isomerase in aspects of dehydrogenation and isomerism
11/23/2011	CN102250843A Genetic engineering marked attenuated vaccine strain of porcine reproductive and respiratory syndrome virus and application thereof
11/23/2011	CN102250842A Method for electroporation transfection of insect cells
11/23/2011	CN101680002B A series of recombinant adeno-associated viral vectors, construction methods and uses thereof
11/23/2011	CN101624580B Recombinant baculovirus expressing manually modified and synthesized influenza A H1N1 virus HA-NA-M1 gene
11/22/2011	US8062888 High throughput assays for transmissible spongiform encephalopathies (TSE)
11/22/2011	CA2488058C Adenovirus vector
11/22/2011	CA2450572C Methods for purification of bacterial cells and cell components
11/22/2011	CA2313739C Model animals of human retrovirus infection
11/17/2011	US20110281329 Process and system for the industrial scale purification of bacteriophages intended for bacteriophage therapy
11/17/2011	US20110281261 Vectors
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280905 Live attenuated chimeric porcine circovirus vaccine
11/17/2011	US20110280904 Generation of virus-like particles and use as panfilovirus vaccine
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110278503 Amphiphilic polymers and nanocrystals coated therewith
11/16/2011	EP2386646A1 Gene delivery system and methods of use
11/16/2011	EP2386628A1 Separation of viruses from nucleic acids using a membrane coated with polymeric primary amines
11/16/2011	CN102242148A Recombinant vector, fibroin film modified by transgenic marrow stromal cells and application thereof
11/16/2011	CN102240400A Method for producing rabies vaccine by applying bioreactor and sheet carrier
11/16/2011	CN101025417B IBV-III antigen production process
11/16/2011	CN101012454B Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
11/15/2011	US8058506 Using plasmid to enhance site-specific and/or homologous recombination between heterologous gene sequences and host nuclear DNA; tissue engineering and exogenous gene expression in plants
11/15/2011	US8058050 Cellular permissivity factor for viruses and uses thereof
11/15/2011	US8058049 Process for producing poxviruses and poxvirus compositions
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	US8057806 Viruses comprising mutant ion channel protein
11/15/2011	US8057803 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/15/2011	CA2392877C Improvements in or relating to immune responses to hiv
11/10/2011	WO2011139717A1 Improved production of virus replicon particles in packaging cells
11/10/2011	WO2011138251A1 Lentiviral vector based immunological compounds against malaria
11/10/2011	WO2011138229A1 Novel method
11/10/2011	WO2011138053A2 Modified rodent parvovirus capable of propagating and spreading through human gliomas
11/10/2011	WO2011138040A2 Vaccine against beta-herpesvirus infection and use thereof
11/10/2011	WO2011090712A3 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
11/10/2011	WO2011039646A3 Papilloma virus -like particles for targeted gene delivery
11/10/2011	US20110275139 Recombinant vaccinia virus having hepatitis c virus gene
11/10/2011	US20110275093 Novel use of adenoviruses and nucleic acids that code for said viruses
11/10/2011	US20110274661 Attentuated Herpesvirus Encoding a Mek Pathway Polypeptide
11/10/2011	US20110274659 Biological control agent for plants
11/10/2011	US20110274649 T-cell vaccination with viral vectors via mechanical epidermal disruption
11/09/2011	EP2385145A2 Compostions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays
11/09/2011	EP2385116A1 Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same
11/09/2011	EP2385107A1 Lentiviral vector based immunological compounds against malaria
11/09/2011	EP2384761A1 Modified rodent parvovirus capable of propagating and spreading through human gliomas
11/09/2011	CN1422950B Recombinant gland-related virus expressing human blood angiotonin II receptor I antisense gene and preparation method thereof
11/09/2011	CN102239252A Infectious bronchitis vaccines derived from ib-qx-like strains
11/09/2011	CN102239251A Bovine viral diarrhea virus with a modified erns protein
11/09/2011	CN102239250A Novel method for generation of rna virus
11/09/2011	CN102234661A Preparation method of human papilloma virus virions, exogenous protein expression cassette and expression system
11/09/2011	CN102234637A Preparation for reconstruction influenza A H1N1 virus inactivated vaccine strain (SC/PR8), and use thereof
11/09/2011	CN102234636A Preparation and application of recombinant influenza A (H1N1) virus cold-adapted attenuated live vaccine strain (SC/AAca)
11/09/2011	CN102234635A High-infection quasi-influenza virus preparation as well as special coding sequence and application thereof
11/09/2011	CN102234634A High-transduction-efficiency hepatophilic cell hepatitis C virus pseudo-particle and envelope protein coded sequence thereof
11/09/2011	CN102234311A Separation of viruses and/or protein from nucleic acids with primary amines
11/09/2011	CN101633910B Rotavirus gene recombined strain and construction method and application thereof
11/09/2011	CN101060859B Refrigerator-temperature stable influenza vaccine compositions
11/08/2011	US8052967 Stable adenoviral vectors and methods for propagation thereof
11/08/2011	US8052965 Viruses with enhanced lytic potency
11/08/2011	CA2443290C Neurovirulent strain of the west nile virus and applications thereof
11/08/2011	CA2415399C Use of strains of the parapox ovis virus against organ fibrosis
11/08/2011	CA2333313C Novel methods for rescue of rna viruses
11/08/2011	CA2226312C Method for purifying viruses by chromatography
11/03/2011	WO2011136421A1 Novel primer and method for preparing a recombinant influenza virus using same
11/03/2011	WO2011135734A1 Complex of virus, therapeutic agent comprising same, and therapeutic method
11/03/2011	WO2011134660A1 Production of viral components
11/03/2011	US20110271357 Colon disease targets and uses thereof
11/03/2011	US20110269119 Encoding text into nucleic acid sequences
11/03/2011	US20110269116 Cell Line From Rousettus As Host Cell For Pathogen Amplification
11/02/2011	EP2383346A1 Method of increasing the function of an AAV vector
11/02/2011	EP2383343A2 Recombinant varicella-zoster virus
11/02/2011	EP2382307A2 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.
11/02/2011	EP2147110B1 Novel simian t-cell lymphotropic virus
11/02/2011	CN102229916A Chicken Flavivirus and inactivated vaccine thereof
11/02/2011	CN102229909A Method for inducing bovine induced pluripotent stem cells
11/02/2011	CN102229663A Plant stress resistance correlative protein OsMYB2, coding gene and application thereof
11/02/2011	CN102229660A Truncated human papillomavirus 33 type L1 protein
11/02/2011	CN102228686A Process for preparing veterinary rabies inactivated and freeze-dried vaccine through suspension culture cell
11/02/2011	CN102228685A Preparation method of iridovirus cell inactivated vaccine for Chinese giant salamanders, and application method thereof
11/01/2011	US8048430 Influenza hemagglutinin and neuraminidase variants
11/01/2011	US8048427 Subgenomic replicons of the flavivirus dengue
11/01/2011	CA2366056C Non-spreading pestivirus
11/01/2011	CA2302992C Methods for generating high titer helper-free preparations of recombinant aav vectors
11/01/2011	CA2221192C Embedded expression of heterologous proteins
10/2011
10/27/2011	WO2011133933A2 Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)
10/27/2011	WO2011133902A2 Cell culture medium comprising small peptides
10/27/2011	US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011	US20110263690 Methods and Compositions for use in Gene Therapy for Treatment of Hemophilia
10/27/2011	US20110263535 Tyrosine-based prodrugs of antiviral agents

1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 267